Hybrid PET/MRI systems provide better anatomical delineation of prostate gland compared to hybrid PET/CT systems due to better soft-tissue resolution of the MRI component, and enable one-stop-shop imaging for prostate cancer patients, including Ga-68 PSMA PET and mpMRI in a single session. The gene discussed is FOLH1; the disease is prostate cancer.